Cite
HARVARD Citation
Eyre, T. et al. (2017). Results of a multicentre UK‐wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting. British journal of haematology. pp. 471-479. [Online].